SHA:600161 Market Cap

SHA:600161 has a market cap or net worth of 28.40 billion as of April 28, 2026. Its market cap has decreased by -29.19% in one year.

Market Cap

28.40B

Enterprise Value

30.15B

Revenue

6.17B

Ranking

n/a

PE Ratio

26.11

Stock Price

14.46

Market Cap Chart

Since March 8, 2000, SHA:600161's market cap has increased from 3.95B to 28.40B, an increase of 619.31%. That is a compound annual growth rate of 7.84%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	28.40B	-12.12%
Dec 31, 2025	32.31B	-20.29%
Dec 31, 2024	40.54B	-20.49%
Dec 29, 2023	50.98B	30.38%
Dec 30, 2022	39.10B	-1.67%
Dec 31, 2021	39.77B	-23.98%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Hualan Biological Engineering	26.44B
Suzhou Zelgen Biopharmaceuticals	26.32B
BrightGene Bio-Medical Technology	25.43B
Xiamen Amoytop Biotech	24.02B
Chongqing Zhifei Biological Products	35.74B
Hebei Changshan Biochemical Pharmaceutical	35.98B
Shanghai RAAS Blood Products	36.19B
Yili Chuanning Biotechnology	21.74B

Market Cap Rankings